Thalidomide, BSE and the single market: An historical-institutionalist approach to regulatory regimes in the European Union

European Journal of Political Research

Volumn 46, Issue 1, 2007, Pages 25-46

  Krapohl, Sebastian ^a  

^a UNIVERSITY OF BAMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846609519     PISSN: 03044130     EISSN: 14756765     Source Type: Journal    
DOI: 10.1111/j.1475-6765.2006.00643.x     Document Type: Review

References (50)

1. Abbott, K.W. et al. (2000). The concept of legalization. International Organization 54(3): 401-419.
2. Alter, K.J. & Meunier-Aitsahalia, S. (1994). Judicial politics in the European Community: European integration and the path-breaking Cassis de Dijon decision. Comparative Political Studies 26(4): 535-561.
3. Arthur, W.B. (1994). Increasing returns and path dependence in the economy. Ann Arbor, MI: University of Michigan Press.
4. Broscheid, A. & Feick, J. (2005). Towards a European FDA? The Review of European Pharmaceuticals Authorization. Paper prepared for delivery at the 2005 meeting of the European Union Studies Association, Austin, TX, 31 March-2 April.
5. Cameron McKenna & Anderson Consulting (2001). Evaluation of the operation of Community procedures for the authorisation of medicinal products. Available online at: http://pharmacos.eudra.org/F2/review/index.htm.
6. Chalmers, D. (2003). Food for thought: Reconciling European risks and traditional ways of life. Modern Law Review 66(4): 532-564.
7. Dehousse, R. (1997). Regulation by networks in the European Community: The role of European agencies. Journal of European Public Policy 4(2): 246-261.
8. European Parliament (1997). Report on the alleged contraventions or maladministration in the implementing of Community law, in relation to BSE, without prejudice to the jurisdiction of the Community and the national courts (AU-0020/97A and B, PE 220.544/fin/A and B). Strasbourg: European Parliament.
9. Feick, J. (2000). Marktzugangsregulierung: Nationale Regulierung, internationale Harmonisierung und europäische Integration. In R. Czada & S. Lütz (eds), Die politische Konstitution von Märkten. Opladen: Westdeutscher Verlag.
10. Feick, J. (2002). Regulatory Europeanization, national autonomy and regulatory effectiveness: Marketing authorization for pharmaceuticals (Discussion Paper 02/6), Max-Planck-Institut für Gesellschaftsforschung.
11. Feick, J. (2005). Learning and interest accommodation in policy and institutional change: EC risk regulation in the pharmaceuticals sector (Discussion Paper 25). London: CARR.
12. Fligstein, N. & Mara-Drita, I. (1996). How to make a market: Reflections on the attempt to create a single market in the European Union. American Journal of Sociology 102(1): 1-33.
13. Gehring, T. & Krapohl, S. (forthcoming). Supranational regulatory agencies between independence and control: The EMEA and the authorisation of pharmaceuticals in the European Single Market. European Public Policy.
14. Joerges, C. & Neyer, J. (1997a). From intergovernmental bargaining to deliberative political processes: The constitutionalisation of comitology. European Law Journal 3(3): 273-299.
15. Joerges, C. & Neyer, J. (1997b). Transforming strategic interaction into deliberative problem-solving: European comitology in the foodstuffs sector. Journal of European Public Policy 4(4): 1350-1763.
16. Kelemen, D.R. (2002). The politics of 'Eurocratic' structure and the new European agencies. West European Politics 25(4): 93-118.
17. Kingdon, J.W. (1995). Agendas, alternatives and public policies (2nd edn). New York: Longman.
18. Kirk, B. (1999). Der Contergan-Fall: Eine unvermeidbare Arzneimittelkatastrophe? Stuttgart: Wissenschaftliche Verlagsgesellschaft.
19. Krapohl, S. (2003). Risk regulation in the EU between interests and expertise: The case of BSE. Journal of European Public Policy 10(2): 189-207.
20. Krapohl, S. (2004). Credible commitment in non-independent regulatory agencies: A comparative analysis of the European agencies for foodstuffs and pharmaceuticals. European Law Journal 10(5): 518-538.
21. Krapohl, S. (2005). Die europäische Arzneimittelzulassung. In: T. Gehring et al. (eds), Rationalität durch Verfahren in der Europäischen Union: Europäische Arzneimittelzulassung und Normung technischer Güter. Baden-Baden: Nomos.
22. Krapohl, S. & Zurek, K. (2006). The perils of committee governance: Intergovernmental bargaining during the BSE scandal in the European Union. European Integration Online Papers 10(2).
23. Krücken, G. (1997). Risikotransformation: Die politische Regulierung technisch-ökologischer Gefahren in der Risikogesellschaft. Opladen: Westdeutscher Verlag.
24. Lewis, G. & Abraham, J. (2001). The creation of neo-liberal corporate bias in medicines control: The industrial shaping and interest dynamics of the European regulatory state. European Journal of Political Research 39: 53-80.
25. Majone, G. (1994). The rise of the regulatory state in Europe. West European Politics 17(3): 77-101.
26. Majone, G. (1996). Regulating Europe. London: Routledge.
27. Majone, G. (1997). The new European agencies: Regulation by information. Journal of European Public Policy 4(2): 262-275.
28. Majone, G. (2000). The credibility crisis of Community regulation. Journal of Common Market Studies 38(2): 273-302.
29. Moravcsik, A. (1991). Negotiating the Single European Act: National interests and conventional statecraft in the European Community. International Organization 45: 19-46.
30. North, D.C. (1992). Institutionen, institutioneller Wandel und Wirtschaftsleistung. Tübingen: Mohr Siebeck.
31. North, D.C. (1993). Institutions and credible commitment. Journal of Institutional and Theoretical Economics 149(1): 11-23.
32. Olson, M. (1968 [1965]). Die Logik des kollektiven Handelns: Kollektivgüter und die Theorie der Gruppen. Tübingen: Mohr Siebeck.
33. O'Rourke, R. (2005). European food law (3rd edn). London: Sweet & Maxwell.
34. Pierson, P. (1996). The path to European integration: A historical institutionalist analysis. Comparative Political Studies 29(2): 123-163.
35. Pierson, P. (2000). Increasing returns, path dependence and the study of politics. American Political Science Review 94(2): 251-267.
36. Scharpf, F.W. (1985). Die Politikverflechtungs-Falle: Europäische Integration und deutscher Föderalismus im Vergleich. Politisch Vierteljahresschrift 26(4): 323-356.
37. Scharpf, F.W. (1999). Governing in Europe: Effective and democratic? Oxford: Oxford University Press.
38. Schelling, T.C. (1978). Hockey helmets, daylight saving and other binary choices. In Micromotives and Macrobehaviour. New York: Norton.
39. Shapiro, M. (1992). The giving-reasons requirement. University of Chicago Law Forum 180-220.
40. Shepsle, K.A. (1986). Institutional equilibrium and equilibrium institutions. In H. Weisberg (ed.), Political science: The science of politics. New York: Agathon.
41. Shepsle, K.A. (1989). Studying institutions: Some lessons from the rational choice approach. Journal of Theoretical Politics 1(2): 131-147.
42. Shepsle, K.A. (1991). Discretion, institutions and the problem of government commitment. In P. Bourdieu & J.S. Coleman (eds), Social theory for a changing society. Boulder, CO: Westview Press.
43. Stone Sweet, A. & Caporaso, J.A. (1998). From free trade to supranational polity: The European Court and integration. In W. Sandholtz & A. Stone Sweet (eds), European integration and supranational governance. Oxford: Oxford University Press.
44. Szawlowska, K. (2004). Risk assessment in the European Food Safety Regulation: Who is to decide whose science is better? Commission v. France and beyond . . . German Law Journal 5(10): 1259-1274.
45. Vogel, D. (1998). The globalization of pharmaceutical regulation. Governance: An International Journal of Policy and Administration 11(1): 1-22.
46. Vogel, D. (2001). The new politics of risk regulation in Europe (Working Paper). London: Centre for Analysis of Risk and Regulation at the London School of Economics and Political Science.
47. Vos, E. (1999). Institutional frameworks of Community health and safety legislation: Committees, agencies and private bodies. Oxford: Hart.
48. Vos, E. (2000). EU food safety regulation in the aftermath of the BSE crisis. Journal of Consumer Policy 23: 227-255.
49. Vos, E. (2004). Overcoming the crisis of confidence: Risk regulation in an enlarged European Union (Working Paper). Maastricht: Universiteit Maastricht.
50. Wilson, J.Q. (1980) (ed.). The politics of regulation. New York: Basic Books.